Betadona wound gel 250 gr

Povidone-iodine has a comprehensive germicidal effect. It is effective against bacteria, fungi, spores, viruses and protozoa.
Betadona Wound Gel enables reliable wound disinfection, largely prevents the formation of pus and promotes rapid, problem-free healing.
A resistance of infectious agents (resistance) to povidone-iodine is not to be feared due to the mode of action.
By binding to povidone, the iodine largely loses the irritating properties of alcoholic iodine preparations and is well tolerated by the skin, mucous membranes and wounds. During the process of action, the iodine discolors, so the depth of the brown color indicates its effectiveness. In the event of discoloration, additional dosing is required. Povidone iodine is water soluble and easily washable.

field of use

For repeated, temporary use

• burns
• cuts and abrasions
• Pressure and lower leg ulcers (decubitus, varicose ulcers)
• infected and superinfected skin diseases

Contraindications

Betadona Wound Gel must NOT be used

• if you are allergic to povidone-iodine or any of the other ingredients of this medicine (listed in section 6),
• if you suffer from an overactive thyroid gland (hyperthyroidism) or other thyroid diseases,
• if you suffer from the rare chronic skin inflammation dermatitis herpetiformis Duhring,
• before and after radiotherapy of the thyroid gland with iodine (radio-iodine therapy) until the end of the treatment, 

interactions

DO NOT use at the same time

• Betadona wound gel and hydrogen peroxide, enzymatic or silver and taurolidine-containing wound treatment agents or disinfectants, as there is a mutual weakening of the effect,
• Betadona wound gel and preparations containing mercury, since a corrosive compound (mercury iodide) can form,
• Betadona wound gel and wound treatment agents containing octenidin, since dark discolouration can temporarily occur,
• Betadona Wound Gel and Taurolidine, a chemotherapy drug against bacteria and fungi, because taurolidine can be converted to an acid (formic acid) that causes intense burning.

Protein, blood or pus components can impair the effectiveness of Betadona Wound Gel.
If you are receiving lithium therapy, Betadona Wound Gel should be used with caution and only for a short time. In this case, larger amounts of iodine can be absorbed through the skin.

Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
An application in pregnant women and during the lactation period may only be carried out on the express instructions of the doctor; monitoring of thyroid function in the mother or infant is indicated. A treatment should only last a short time. Iodine enters the fetus (unborn child) via the placenta (placenta) and also passes into breast milk.
Accidental ingestion of Betadona Wound Gel by the infant through contact with the treated part of the nursing mother's body must be avoided.

application

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is:
The wound gel is applied evenly to the affected area several times a day.
If the Betadona Wound Gel has become discolored, it should be replenished. Do not use Betadona Wound Gel together with other wound treatment products.

Betadona Wound Gel is intended for external use.

Duration of use
Betadona Wound Gel should be used as long as there are still signs of infection or a clear risk of infection. If a recurrence occurs after discontinuing treatment with Betadona Wound Gel, treatment can be restarted at any time.

Newborns and infants under
the age of 6 months Betadona Wound Gel should only be used in newborns and infants up to the age of 6 months after a strict benefit/risk assessment by the doctor and is extremely limited. 

side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following definitions for adverse drug reaction frequencies were used:

Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people Affects those treated
Not known:
frequency cannot be estimated from the available data

Immune system disorders
Rare: Hypersensitivity
Very rare: Acute general allergic reactions (anaphylactic reactions) often accompanied by a drop in blood pressure, dizziness, nausea and possibly shortness of breath

Endocrine disorders (glands and hormones)
Very rare: hyperthyroidism in patients prone to it ¹⁾
Not known: hypothyroidism ²⁾

Metabolism and nutritional disorders
Not known: Disorders of the electrolyte balance ³⁾ , metabolism-related hyperacidity of the blood and the body ³⁾

Skin and subcutaneous tissue disorders
Rare: Hypersensitivity reactions of the skin, which can manifest themselves in the form of itching, redness, blisters or similar
Very rare: Allergic, painful swelling of the skin and mucous membrane (angioedema)

Renal and urinary tract disorders
Not known: acute renal failure ³⁾ , number of dissolved substances in the blood too large or too small ³⁾

¹⁾ In patients with a history of thyroid dysfunction (see Special Warnings and Precautions for Use) after ingestion of a large amount of iodine, for example, in the course of extensive application of povidone-iodine in the treatment of wounds and burns over a long period of time
²⁾ Hypothyroidism after prolonged or excessive use of povidone-iodine
³⁾ May occur after ingestion of large amounts of povidone-iodine (e.g. treatment of burns). 

composition

The active substance is: povidone-iodine
1 g Betadona wound gel contains 100 mg povidone-iodine complex,
total content: 1% available iodine.

The other ingredients are:
macrogol, purified water, sodium bicarbonate.